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Effects of Hepatectomy on the Disappearance Rate of 
Lidocaine from Blood in Man and Dog 
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D EPENDING on their chemical configura-
tion, local anesthetic agents are in-
activated chiefly either in the plasma or in 
the liver. Lidocaine hydrochloride, an anes-
thetic with an amide structure, has been 
thought to be primarily metabolized in the 
liver with little or no extrahepatic degrada-
tion. 1-3 This contention was tested in he-
patectomized dogs with nearly normal car-
diodynamics and, during the anhepatic pe-
riod, in 2 patients undergoing liver trans-
plantation. 
MATERIALS AND METHODS 
Anhepatic Dogs - Five mongrel dogs, 
weighing between 14 and 17 kg., were anes-
thetized with 30 mg./kg. of pentobarbital 
sodium injected intravenously. The femoral 
vein and artery were cannulated. After a 
5 m!. control arterial blood sample was ob-
tained, a 2 percent solution of lidocaine Hel, 
2.5 mg./kg. intravenously, was administered 
during a 30-second period. Arterial blood 
samples were drawn 2, 5, 10, 15, 30, 60, 90, 
and 120 minutes later. One hour after pro-
curement of the last sample, portacaval 
shunt and total hepatectomy were per-
formed, leaving the inferior vena cava in-
tact. 4 This was followed by control sam-
pling, lidocaine injection, and the procure-
ment of blood samples as before. 
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Since hepatectomy is known to be accom-
panied by hypoglycemia and metabolic aci-
dosis, Ii arterial blood gases and pH and 
blood glucose were measured every 15 min-
utes. A solution of 50 percent glucose was 
used to maintain the glucose level between 
130 and 175 mg./l00 ml. Arterial blood 
pressure and heart rate were continuously 
monitored. After hepatectomy two animals 
(dogs 11 and 12) also received an infusion 
of 5 percent glucose in 0.9 percent saline 
solution at a rate of 20 ml./kg./hr., whereas 
dogs 13, 14, and 15 were not given the extra 
infusion. 
Anhepatic Patients - Two adult patients 
undergoing orthotopic liver transplantation, 
as described by Starzl, 6 were studied while 
under anesthesia. Thiopental sodium and 
succinylcholine were administered to induce 
sleep and facilitate orotracheal intubation. 
Thereafter, fluroxene-nitrous oxide-oxygen 
was given by inhalation in a semiclosed-
circle system. After obtaining a control ar-
terial sample, lidocaine HCl, 2.5 mg./kg., 
was given intravenously, and other arterial 
aliquots were obtained at the same intervals 
as described in the dog experiments. During 
this time, the diseased host liver was being 
dissected preparatory to removal but the 
blood supply was intact. 
At least 3 hours after lidocaine injection, 
total host hepatectomy was performed, at 
which time a second injection of lidocaine 
was given and subsequent samples obtained 
at the same time intervals as earlier. The 
homograft was revascularized 50 minutes 
after the local anesthetic agent had been 
injected. However, the schedule of sampling 
was continued as in the preanhepatic stud-
ies, except in patient A, from whom an extra 
sample was obtained 240 minutes after lido-
caine injection. 
Blood and solutions of glucose and sodium 
bicarbonate were infused during these oper-
ations to replace blood loss, prevent hypo-
glycemia, and correct metabolic acidosis 
during the anhepatic phase. The lidocaine 
level in the blood was determined according 
to the technic described by Keenaghan,7 
using a dual-column Aerograph Model 1520 
gas chromatograph, which is sensitive to 
concentrations as low as 0.5 mcg./ml. of 
the local anesthetic in blood. 
RESULTS 
Animal Studies - Blood levels of lido-
caine observed in intact anesthetized dogs 
declined similarly in every instance, being 
0.7 mcg./ml. or less at 60 minutes and 0.5 
mcg./ml. or less at 2 hours after injection. 
After hepatectomy, the 2 dogs that re-
ceived dilute glucose in the intravenous 
saline solution had lidocaine values between 
3.3 and 4.2 mcg. in the immediate postin-
jection period. At 2 hours, these remained 
above 1.2 mcg./ml. (fig. 1). In contrast, 
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FIG. 1. Blood levels observed after intravenous 
injection of lidocaine (2.5 mg.jkg.) into 2 dogs 
under control conditions and after hepatectomy. A 
solution of 5 percent glucose in 0.9 percent saline 
was infused at a rate of 20 ml.jkg.jhr. 
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FIG. 2. Changes of blood levels observed after 
intravenous injection of 2.5 mg.jkg. into 3 dogs 
before and after hepatectomy. The glucose demand 
in these animals was supplied with a concentrated 
solution of dextrose (50 percent). 
the 3 animals that received concentrated 
glucose alone and were not, therefore, he-
modiluted, had initial lidocaine levels rang-
ing from 7.9 to 18.4 mcg./ml. rapidly declin-
ing to levels between 3 and 5 mcg./ml. (fig. 
2). However, the lidocaine concentrations 
remained above 1 mcg./mi. at 120 minutes 
after injection and even at 180 minutes in 
the one sample (figs. 1 and 2). 
Hepatectomized Patients-Preoperatively, 
both patients had severe hepatic insuffi-
ciency, recipient A owing to chronic rejec-
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FIG. 3. Comparison of the rate of lidocaine dis-
appearance from blood after intravenous admin-
istration of 2.5 mg.jkg. in 2 patients with terminal 
cirrhosis undergoing orthotopic transplantation. 
Blood samples in the second series were obtained 
during the anhepatic stage, which lasted 50 minutes 
in both cases. Thereafter, decline of lidocaine levels 
is presumably due to restoration of normal function 
by the homograft. 
tion of a previously transplanted liver and 
recipient B as a result of long-standing cir-
rhosis with repeated hematemesis. Two 
minutes after intravenous injection of lido-
caine, the blood levels were 6.6 and 5 meg./ 
mi., respectively, and fell to 1.5 and 1.7 
mcg./mi. at 1 hour, and to 1.1 and 1.4 
mcg./mi. at 2 hours (fig. 3). After revascu-
larization, a downward trend of the arterial 
blood levels was apparent, to a degree that 
4 hours after injection, the concentration of 
lidocaine was only 0.4 mcg./mi. 
Neither dogs nor patients showed toxic 
manifestations from the lidocaine injections. 
DISCUSSION 
After entry into the blood stream, the 
disposition of a number of local anesthetic 
agents such as procaine occurs by prompt 
degradation subserved by the enzyme pseu-
docholinesterase. 8 ,9 Disappearance of lido-
caine Hel is less dependent upon metabolic 
degradation and more upon its high lipid 
solubility permitting rapid distribution in 
tissue. l However, the ultimate metabolism 
of lidocaine has been said to take place in 
the liver by microsomal enzymes with re-
duced Nicotinamide-adenine dinucleotide 
phosphate and oxygen,l,:J,lO undergoing ei-
ther oxidation first, or hydrolysis followed 
by oxidation prior to sulfate conjugation. l1 
A prediction, based on the foregoing facts, 
that the early phase of lidocaine disappear-
ance would be less affected by the liverless 
state than the late phase, proved valid both 
in dogs and in man. The canine experiments 
were the most decisive, since transfusions 
were not ordinarily required during hepa-
tectomy and because an excellent cardiody-
namic state could be maintained at all times. 
With these conditions, most of the lidocaine 
disappeared from the blood in the first 
hour, although at a somewhat slower rate 
than normal. Thereafter, the fall in blood 
levels either declined very slowly or not at 
all, suggesting that equilibration had occur-
red. Presumably, further elimination would 
then depend upon other routes (kidney or 
gastrointestinal tract). If extrahepatic de-
gradation occurred at all, it must have been 
a t an imperceptible pace. 
Despite the seriously diseased livers in 
the 2 human subjects, early disappearance 
of lidocaine was rapid, presumably because 
of prompt tissue distribution. In the ensuing 
40 minutes, blood concentrations decreased 
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slowly but steadily. During the anhepatic 
state, the tissue distribution phase was also 
noted but the subsequent decline of lidocaine 
concentration was not so rapid, the levels 
remaining above 2.5 mcg./ml. even 45 min-
utes after the new liver had been revascu-
larized. Ultimately, the homograft appar-
ently assumed the burden of lidocaine degra-
dation, since by 4 hours after revasculariza-
tion, the concentration was only 0.4 mcg./ 
ml. Although not of practical significance, 
lidocaine clearance from blood could be 
interpreted as a sign of acceptable liver 
homograft function. 
In this investigation, it was necessary to 
give two doses of the drug tested. A criticism 
of the protocol might be that the adminis-
tered agent could accumulate in the tissues 
and contribute to an artificially high value 
after the second injection.12 Such an ex-
planation would not seem to account for the 
results in the present study, first because the 
doses were small; second, because lidocaine 
disappeared almost completely before the 
second injection in the presence of the liver; 
and finally, because, in the human experi-
ence, the restoration of liver function with 
the homograft was attended by a secondary 
late acceleration of lidocaine disappearance. 
SUMMARY 
The disappearance from blood of intra-
venously injected lidocaine HCI was studied 
in 5 dogs before and after total hepatectomy. 
In the intact state, the lidocaine concentra-
tions in the blood fell rapidly at first and 
more slowly in the late phase. After hepa-
tectomy, the disappearance rates were re-
duced both early and late after injection. 
The findings were consistent with the hy-
pothesis that the liver is responsible for 
the ultimate disposition of lidocaine. 
Analogous experiments were performed 
in 2 patients with terminal cirrhosis under-
going orthotopic liver transplantation. The 
results indicated that the conclusions from 
the animal experiments pertained as well 
in humans. 
Generic and Trade Names of Drugs 
Lidocaine (HCI) -Xylocaine 
Procaine CHCI)-Novocain 
Pentobarbital sodium-Nembutal 
Sodium thiopental-Pentothal Sodium 
Succinylcholine-Anectine, Quelicine 
Fluoroxene-Fluoromar 
Sodium bicarbonate 
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